EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

LOGO

 

OMNIVISION REPORTS FOURTH QUARTER AND FISCAL 2004 RESULTS AND

RESTATEMENT OF THE FIRST, SECOND AND THIRD QUARTERS OF FISCAL 2004

 

SUNNYVALE, Calif. – June 23, 2004 – OmniVision Technologies, Inc. (Nasdaq:OVTI) reported that in the three months ended April 30, 2004, the fourth quarter of its fiscal year 2004, it earned net income of $20.8 million, or $0.34 per diluted share, on revenue of $99.7 million. In the fourth quarter of fiscal year 2003, the Company earned net income of $6.1 million, or $0.12 per diluted share, on revenue of $39.9 million.

 

In fiscal year 2004, the Company earned net income of $58.7 million, or $0.98 per diluted share, on revenue of $318.1 million. In fiscal year 2003, the Company earned net income of $15.3 million, or $0.31 per diluted share, on revenue of $109.0 million.

 

“Fiscal year 2004 was a period of dramatic expansion for our business,” said Shaw Hong, president and chief executive officer. “Our revenue grew by 192% year to year, as the cameraphone market emerged as our largest market segment. To build our organization, we expanded our testing operations in mainland China and opened new sales offices in several international markets. To enhance quality and deliverability, we made rapid progress with our manufacturing joint venture, VisEra, that we started with our foundry partner, Taiwan Semiconductor Manufacturing Company. This year we achieved growth that was unprecedented in our history and we emerged as a powerful force in the image sensor market. We are committed to an aggressive strategy of leveraging our many new products to support our current markets and to address large, developing markets.”

 

For the three months ended April 30, 2004, gross profit was $40.1 million, or 40.3% of revenue. In the comparable period a year ago, gross profit was $15.4 million, or 38.4% of revenue. For the three months ended April 30, 2004, direct sales to original equipment manufacturers and value-added resellers accounted for approximately 80% of revenue, with the balance of approximately 20% coming from sales through distributors. During the quarter, total cash, cash equivalents and short-term investments increased by $18.1 million, to $215.2 million. As of April 30, 2004, working capital was $271.9 million, and stockholders’ equity was $300.0 million.

 

For the quarter ending July 31, 2004, the first quarter of fiscal 2005, the Company currently expects to report $95 million to $100 million in revenue and $0.29 to $0.31 in diluted earnings per share.

 

As previously disclosed, Omnivision has been conducting an internal review, a review which was initiated in response to issues raised by an employee. The Company notified the Audit Committee of the Board of Directors of the issues raised, and the Audit Committee conducted an independent


investigation in cooperation with special legal counsel. As a result of the internal review and the independent investigation, management and the Audit Committee determined that certain errors had occurred which principally affected the timing of revenue recognition for certain sales.

 

The independent investigation concluded that there was no evidence of wrongdoing in connection with these errors. The Company, under direction from the Audit Committee, is in the process of making improvements to its internal controls and information systems.

 

As a result of the errors identified, Omnivision is restating its financial results for the first, second and third quarters of fiscal 2004. For the nine months ended January 31, 2004, the restatement increases revenue by $8.9 million, net income by $2.7 million and diluted earnings per share by $0.04 over the amounts previously reported.

 

The restatement of the Company’s financial results for first three quarters of fiscal 2004 relates primarily to two issues. First, beginning in the second half of fiscal 2003 and continuing through the first nine months of fiscal 2004, certain distribution sales, for which the Company recognizes revenue on a “sell-through” basis, were not reported to the Company by one of its distributors in a timely manner. Additionally, in the second and third quarters of fiscal 2004, during the transition of testing operations and certain international sales functions to overseas locations, some shipments made to customers late in the quarter were incorrectly classified as transferring title upon delivery as opposed to upon shipment, and therefore revenue was not recognized when product was shipped. Both of these issues resulted in delayed revenue recognition. Both management and the Audit Committee determined that the errors did not have material effects on quarterly or annual financial statements for fiscal 2003 and, consequently, decided not to restate the quarterly or annual financial results for such periods. The following table summarizes the effect of the restatement on each of first three quarters of fiscal 2004:

 

     Quarter Ended

     July 31, 2003

   October 31, 2003

   January 31, 2004

     As Reported

   Restated

   As Reported

   Restated

   As Reported

   Restated

     (in millions, except diluted earnings per share figures)

Revenues

   $ 46.5    $ 46.8    $ 68.5    $ 78.0    $ 94.5    $ 93.6

Net income

   $ 6.2    $ 6.2    $ 11.6    $ 13.8    $ 17.3    $ 17.9

Earnings per share – Diluted

   $ 0.12    $ 0.12    $ 0.19    $ 0.23    $ 0.28    $ 0.29

 

The Company currently anticipates filing amended Quarterly Reports on Form 10-Q for the first, second and third quarters of 2004 and its 2004 Annual Report on Form 10-K by July 14, 2004. The amended quarterly reports will contain the restated financial results described above.

 

Teleconference

 

At 1:30 p.m. PDT (4:30 p.m. EDT) today, June 23, 2004, the Company will hold a teleconference to discuss financial results and future plans and prospects. To participate in the teleconference, please call (toll free) 877-523-2171 approximately 10 minutes prior to the start time. For international callers, the dial-in number is 706-634-1478. You may also listen live via the Internet at the Company’s website, www.ovt.com, or at www.FullDisclosure.com.


These websites will host an archive of the teleconference. Additionally, a playback of the call will be available for 48 hours beginning today at 4:30 p.m. PDT. You may access the playback by calling 800-642-1687, or for international callers 706-645-9291, and providing Conference ID number 7181515.

 

About OmniVision

 

OmniVision Technologies designs, develops and markets high performance, highly integrated and cost efficient semiconductor image sensors. OmniVision’s main product, an image sensing device called the CameraChipTM, is used to capture images in mass-market consumer and commercial applications such as mobile phones, digital still cameras and video game systems. OmniVision believes that the CameraChip is one of the most highly integrated single-chip CMOS image sensor solutions available and that it enables manufacturers to build camera products that are smaller, less complex, more reliable, lower cost and more power efficient than cameras using either traditional CCDs or multiple-chip CMOS image sensors. OmniVision’s CameraChips are used in a wide variety of applications, including mobile phones, digital still cameras, video cameras, interactive video games, toys, security and surveillance systems, personal computer cameras, personal digital assistants and automotive imaging systems. OmniVision Technologies is headquartered at 1341 Orleans Drive, Sunnyvale, CA 94089. Additional information is available at www.ovt.com.

 

OmniVision and CameraChip are trademarks of OmniVision Technologies, Inc.

 

Safe-Harbor Statement

 

Certain statements in this press release, including statements relating to the Company’s expectations regarding revenue and earnings per share for the quarter ending July 31, 2004 and the Company’s strategy at leveraging its many new products to address existing and developing markets, are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, and actual results may differ materially from those projected as a result of certain risks and uncertainties. These risks and uncertainties include, without limitation, the following: the degree to which intense competition might affect the Company’s ability to compete successfully in current and emerging markets for image sensor products; risks associated with the Company’s ability to obtain design wins from camera, mobile phone and other image sensor device manufacturers, which could inhibit the Company’s ability to sustain and grow its business; risks associated with wafer manufacturing yields and other manufacturing processes, which could materially and adversely affect the Company’s revenue and earnings and its ability to satisfy customer demand; risks associated with the Company’s planned streamlining and consolidation of manufacturing processes, which could adversely affect the Company’s operating expenses and its ability to sustain and expand its business; risks associated with the development of current and emerging markets for CMOS image sensor products, generally, and the Company’s products, specifically, which could result in lower revenue and earnings and adversely affect the Company’s business and prospects; risks associated with the Company’s ability to accurately


forecast customer demand for its products which could impair the Company’s ability to meet customer demand for CameraChip products and could also result in excess inventory; risks associated with the development of new products, which would adversely affect the Company’s ability to compete successfully in the CMOS image sensor market; the Company’s dependence upon a few key customers, the loss of one or more of which could materially and adversely affect the Company’s business and results of operations; uncertainties associated with the Company’s decision to restate certain of its fiscal 2004 quarterly results of operation; a decline in the average selling price of the Company’s products, which could result in a decline in the Company’s revenue and gross margins; and the other risks detailed from time to time in the Company’s Securities and Exchange Commission filings and reports, including, but not limited to, the Company’s most recent annual report filed on Form 10-K and most recent quarterly report filed on Form 10-Q. The Company disclaims any obligation to update information contained in any forward-looking statement.

 

Contact:

 

OmniVision Technologies, Inc.

 

John T. Rossi, 408-542-3000

 

Silverman Heller Associates

 

Philip Bourdillon/Eugene Heller, 310-208-2550

 

# # #


OMNIVISION TECHNOLOGIES, INC.

 

CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     April 30,

 
     2004

    2003

 

Assets

                

Current assets:

                

Cash and cash equivalents

   $ 198,053     $ 50,438  

Restricted cash

     1,072        

Short-term investments

     17,158       10,224  

Accounts receivable, net

     53,513       19,133  

Inventories

     38,802       13,642  

Refundable and deferred income taxes

     6,518       7,642  

Prepaid expenses and other assets

     2,626       1,195  
    


 


Total current assets

     317,742       102,274  

Property, plant and equipment, net

     20,622       12,456  

Long-term investments

     7,110       2,845  

Other non-current assets

     362       378  
    


 


Total assets

   $ 345,836     $ 117,953  
    


 


Liabilities and Stockholders’ Equity

                

Current liabilities:

                

Accounts payable

   $ 25,923     $ 10,528  

Accrued expenses and other liabilities

     11,100       8,037  

Deferred income

     8,800       2,845  
    


 


Total current liabilities

     45,823       21,410  
    


 


Stockholders’ equity:

                

Common stock, $0.001 par value; 100,000 shares authorized; 56,212 and 46,806 and shares issued and outstanding at April 30, 2004 and 2003, respectively

     56       47  

Additional paid-in capital

     249,401       104,824  

Deferred compensation related to stock options

     (20 )     (159 )

Retained earnings (accumulated deficit)

     50,576       (8,169 )
    


 


Total stockholders’ equity

     300,013       96,543  
    


 


Total liabilities and stockholders’ equity

   $ 345,836     $ 117,953  
    


 



OMNIVISION TECHNOLOGIES, INC.

 

CONSOLIDATED INCOME STATEMENTS

(in thousands, except per share amounts)

 

    

Three Months Ended

April 30,


  

Year Ended

April 30,


     2004

   2003

   2004

   2003

Revenues

   $ 99,673    $ 39,943    $ 318,123    $ 108,998

Cost of revenues

     59,553      24,587      194,106      66,904
    

  

  

  

Gross profit

     40,120      15,356      124,017      42,094
    

  

  

  

Operating expenses:

                           

Research and development

     4,682      3,299      15,500      11,550

Selling, general and administrative

     5,453      3,125      21,356      10,784

Stock-based compensation

     93      66      1,099      398
    

  

  

  

Total operating expenses

     10,228      6,490      37,955      22,732
    

  

  

  

Income from operations

     29,892      8,866      86,062      19,362

Interest income, net

     415      171      1,696      802

Other income

     1,250           1,250     
    

  

  

  

Income before income taxes

     31,557      9,037      89,008      20,164

Provision for income taxes

     10,730      2,948      30,263      4,840
    

  

  

  

Net income

   $ 20,827    $ 6,089    $ 58,745    $ 15,324
    

  

  

  

Net income per share:

                           

Basic

   $ 0.37    $ 0.13    $ 1.11    $ 0.34
    

  

  

  

Diluted

   $ 0.34    $ 0.12    $ 0.98    $ 0.31
    

  

  

  

Shares used in computing net income per share:

                           

Basic

     55,811      46,457      52,856      45,357
    

  

  

  

Diluted

     60,846      51,046      59,688      50,200
    

  

  

  

 


OMNIVISION TECHNOLOGIES, INC.

 

CONSOLIDATED INCOME STATEMENTS

(in thousands, except per share amounts)

 

     Three Months Ended

    

July 31,

2003


  

October 31,

2003


  

January 31,

2004


  

April 30,

2004


     (Restated)    (Restated)    (Restated)     

Revenues

   $ 46,839    $ 77,998    $ 93,613    $ 99,673

Cost of revenues

     29,460      48,425      56,668      59,553
    

  

  

  

Gross profit

     17,379      29,573      36,945      40,120
    

  

  

  

Operating expenses:

                           

Research and development

     3,580      3,173      4,065      4,682

Selling, general and administrative

     4,490      5,904      5,509      5,453

Stock-based compensation

     101      95      810      93
    

  

  

  

Total operating expenses

     8,171      9,172      10,384      10,228
    

  

  

  

Income from operations

     9,208      20,401      26,561      29,892

Interest income, net

     222      548      511      415

Other income

                    1,250
    

  

  

  

Income before income taxes

     9,430      20,949      27,072      31,557

Provision for income taxes

     3,206      7,123      9,204      10,730
    

  

  

  

Net income

   $ 6,224    $ 13,826    $ 17,868    $ 20,827
    

  

  

  

Net income per share:

                           

Basic

   $ 0.13    $ 0.26    $ 0.33    $ 0.37
    

  

  

  

Diluted

   $ 0.12    $ 0.23    $ 0.29    $ 0.34
    

  

  

  

Shares used in computing net income per share:

                           

Basic

     47,696      53,946      54,652      55,811
    

  

  

  

Diluted

     53,638      60,296      60,850      60,846